147 related articles for article (PubMed ID: 19796195)
21. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
22. Dosage of gadoteridol and adverse reactions relative to gadopentetate.
Hieronim DE; Kanal E; Swanson DP
Am J Health Syst Pharm; 1995 Nov; 52(22):2556-9. PubMed ID: 8590239
[TBL] [Abstract][Full Text] [Related]
23. How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
Perazella MA
Clin J Am Soc Nephrol; 2008 May; 3(3):649-51. PubMed ID: 18385396
[No Abstract] [Full Text] [Related]
24. Epinephrine administration for severe adverse reactions to contrast agents.
Samett EJ; Espinosa GA
Radiology; 1995 Sep; 196(3):879. PubMed ID: 7644663
[No Abstract] [Full Text] [Related]
25. Gadolinium deposition disease: Initial description of a disease that has been around for a while.
Semelka RC; Ramalho J; Vakharia A; AlObaidy M; Burke LM; Jay M; Ramalho M
Magn Reson Imaging; 2016 Dec; 34(10):1383-1390. PubMed ID: 27530966
[TBL] [Abstract][Full Text] [Related]
26. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
Saab G; Abu-Alfa A
Radiology; 2007 Sep; 244(3):930-1; author reply 931-2. PubMed ID: 17709844
[No Abstract] [Full Text] [Related]
27. Anaphylaxis after first exposure to gadoterate meglumine: a case report and literature review.
Bianchi L; Hansel K; Marietti R; Tramontana M; Stingeni L
J Allergy Clin Immunol Pract; 2018; 6(6):2124-2126. PubMed ID: 29559210
[No Abstract] [Full Text] [Related]
28. Tolerability of gadobenate dimeglumine in a patient with reported allergy to gadoterate meglumine.
Moulin C; Said BB; Berard F
AJR Am J Roentgenol; 2011 Dec; 197(6):W1163. PubMed ID: 22109336
[No Abstract] [Full Text] [Related]
29. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment.
Hasdenteufel F; Luyasu S; Renaudin JM; Paquay JL; Carbutti G; Beaudouin E; Moneret-Vautrin DA; Kanny G
J Allergy Clin Immunol; 2008 Feb; 121(2):527-8. PubMed ID: 17919712
[No Abstract] [Full Text] [Related]
30. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
[TBL] [Abstract][Full Text] [Related]
31. Anaphylaxis to gadobenate dimeglumine (Multihance): a case report.
Kalogeromitros DC; Makris MP; Aggelides XS; Spanoudaki N; Gregoriou SG; Avgerinou G; Rigopoulos DG
Int Arch Allergy Immunol; 2007; 144(2):150-4. PubMed ID: 17536224
[TBL] [Abstract][Full Text] [Related]
32. Incidence and severity of acute adverse reactions to four different gadolinium-based MR contrast agents.
Okigawa T; Utsunomiya D; Tajiri S; Okumura S; Sasao A; Wada H; Oda S; Arimura H; Hayashida E; Urata J; Yamashita Y
Magn Reson Med Sci; 2014; 13(1):1-6. PubMed ID: 24492735
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
[TBL] [Abstract][Full Text] [Related]
34. Clinical Safety of Gadoteridol, Representative of the Macrocyclic Class of Gadolinium-Based Contrast Agents.
Runge VM
J Magn Reson Imaging; 2020 Mar; 51(3):869-870. PubMed ID: 31614049
[No Abstract] [Full Text] [Related]
35. Considerations in the choice of contrast media for MR imaging.
Brasch RC; Bennett HF
Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795
[No Abstract] [Full Text] [Related]
36. Severe adverse reaction to iv gadopentetate dimeglumine.
Takebayashi S; Sugiyama M; Nagase M; Matsubara S
AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
[No Abstract] [Full Text] [Related]
37. Anaphylactic reaction and cardiac arrest due to gadobenate dimeglumine.
Virtos M; Ruiz S; Mokrane FZ; Rousseau H; Georges B; Fourcade O; Conil JM
Anaesth Crit Care Pain Med; 2015 Aug; 34(4):247-8. PubMed ID: 26004876
[No Abstract] [Full Text] [Related]
38. Imaging patients with kidney disease: how do we approach contrast-related toxicity?
Perazella MA; Reilly RF
Am J Med Sci; 2011 Mar; 341(3):215-21. PubMed ID: 21139495
[TBL] [Abstract][Full Text] [Related]
39. Eye and testicular pain after administration of gadopentetate dimeglumine.
Padhani AR; Lopez AJ; Revell PB; MacVicar DA
AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
[No Abstract] [Full Text] [Related]
40. Acute side effects of three commonly used gadolinium contrast agents in the paediatric population.
Neeley C; Moritz M; Brown JJ; Zhou Y
Br J Radiol; 2016 Jul; 89(1063):20160027. PubMed ID: 27194459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
